News
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...
NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans.
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
6d
Zacks Investment Research on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results